“SVRN creates opportunities to deploy capital where financial returns and societal benefit reinforce each other, supporting innovation that improves patient outcomes while delivering disciplined, risk-adjusted returns.“
Oswald Bentinck
Tied to products, not to markets
Our approach allows investors to access product-level, contractual cash flows that are uncorrelated to public market performance. Opportunities are sourced by a specialized life sciences team with deep domain expertise across pricing, reimbursement, launch, and commercialization.
Ask us a question
Learn more
Transparent Returns
Our financing format enables incremental return of capital which is not dependent on corporate exits. Each financing has a defined duration over a horizon in the range of 4–8 years, tied to commercial revenue.
Ask us a question
Learn more
Structured To Protect
We work with companies to design each investment vehicle to safeguard investor capital. Capital disbursement is gated on milestones such as performance relative to forecast targets. We manage binary clinical or regulatory risk.
Ask us a question
Learn more
